GALVUS MET 50/1000 15s

About

GALVUS MET 50/1000 is an oral antidiabetic medication combining vildagliptin (50 mg) and metformin hydrochloride (1000 mg), specifically formulated for the management of type 2 diabetes mellitus. Vildagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, works by preventing the breakdown of incretin hormones, GLP-1 and GIP, which are naturally released in response to food intake. This action enhances glucose-dependent insulin secretion from pancreatic beta cells and suppresses glucagon secretion from alpha cells, thereby improving glycemic control. Metformin, a biguanide, complements this action by reducing glucose production in the liver, decreasing glucose absorption from the gut, and enhancing insulin sensitivity in peripheral tissues. This dual mechanism effectively targets multiple pathways involved in hyperglycemia, making it a potent option for patients whose blood glucose is inadequately controlled by diet, exercise, or monotherapy.

Uses

• Treatment of type 2 diabetes mellitus.
• Improvement of glycemic control.
• Used as an adjunct to diet and exercise.
• Monotherapy or in combination with other antidiabetic agents.

Directions For Use

Take orally, usually twice daily with meals, as directed by your physician. Swallow tablets whole with water.

Benefits

• Provides comprehensive glycemic control through two distinct mechanisms.
• Effectively lowers HbA1c levels.
• Generally associated with a low risk of hypoglycemia.
• Can contribute to modest weight loss or be weight neutral.
• Improves both fasting and postprandial glucose levels.
• Offers the convenience of a fixed-dose combination.

Side Effects

• Gastrointestinal disturbances (e.g., nausea, diarrhea, vomiting).
• Abdominal pain or discomfort.
• Headache, dizziness.
• Nasopharyngitis.
• Tremor.
• Fatigue.
• Hypoglycemia (especially when combined with insulin or sulfonylureas).
• Lactic acidosis (rare but serious, associated with metformin).
• Joint pain (arthralgia).
• Skin reactions (e.g., rash).
• Pancreatitis (rare).
• Vitamin B12 deficiency with prolonged use.

Safety Measures

• Alcohol - Avoid excessive alcohol intake due to an increased risk of lactic acidosis, a rare but serious side effect associated with metformin.
• Pregnancy - Generally not recommended during pregnancy; consult your doctor. Insulin is typically the preferred treatment for diabetes in pregnant women.
• Breastfeeding - Not recommended during breastfeeding as metformin is excreted into breast milk and vildagliptin's excretion into human milk is unknown.
• Liver - Contraindicated in severe hepatic impairment due to the metformin component; vildagliptin is also not recommended in patients with elevated liver enzymes.
• Kidney - Contraindicated in severe renal impairment (eGFR <30 mL/min/1.73m²) due to the risk of metformin accumulation and lactic acidosis.
• Lung - Use with caution in severe respiratory conditions that may predispose to hypoxia, as this can increase the risk of lactic acidosis with metformin.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.